Scarica l'app Stockscreener
158.52
0.37%
0.59
Pre-mercato:
157.26
-1.26
-0.79%
Precedente Chiudi:
$157.93
Aprire:
$158.55
Volume 24 ore:
304.99K
Relative Volume:
0.62
Capitalizzazione di mercato:
$5.09B
Reddito:
$560.03M
Utile/perdita netta:
$-150.66M
Rapporto P/E:
-32.62
EPS:
-4.86
Flusso di cassa netto:
$-87.43M
1 W Prestazione:
-2.36%
1M Prestazione:
+16.35%
6M Prestazione:
+40.23%
1 anno Prestazione:
+127.50%
Intervallo 1D:
$156.53
$159.62
Intervallo di 1 settimana:
$152.05
$168.09
Portata 52W:
$55.92
$168.32
Irhythm Technologies Inc Stock (IRTC) Company Profile
Nome
Irhythm Technologies Inc
Settore
Industria
Telefono
415-632-5700
Indirizzo
699 8TH STREET, San Francisco, CA
Confronta IRTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
158.52 | 5.16B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
131.25 | 229.31B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.75 | 152.87B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
389.94 | 146.01B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
89.90 | 119.18B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.93 | 45.95B | 5.69B | 1.41B | 577.90M | 6.95 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Ripresa | Wells Fargo | Equal Weight |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-06-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-02-07 | Iniziato | Wells Fargo | Overweight |
| 2022-11-07 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-06 | Iniziato | Wolfe Research | Underperform |
| 2022-02-24 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-18 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Ripresa | Canaccord Genuity | Buy |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-06-02 | Downgrade | Citigroup | Buy → Neutral |
| 2021-04-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-04-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Downgrade | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Reiterato | Needham | Hold |
| 2020-11-17 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Iniziato | Needham | Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-08-07 | Aggiornamento | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-10 | Iniziato | William Blair | Outperform |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-10-22 | Iniziato | Oppenheimer | Perform |
| 2019-02-20 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Reiterato | Canaccord Genuity | Buy |
| 2018-09-06 | Iniziato | Chardan Capital Markets | Buy |
| 2018-08-02 | Aggiornamento | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Downgrade | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Iniziato | Dougherty & Company | Neutral |
Mostra tutto
Irhythm Technologies Inc Borsa (IRTC) Ultime notizie
iRhythm Technologies (IRTC) Surpasses Q2 Revenue Forecasts, Raises Outlook - MSN
AVALON Study Builds on CAMELOT Study Reinforcing iRhythm’s LTCM Clinical Performance - Diagnostic and Interventional Cardiology
iRhythm Technologies falls after Spruce Point issues short-selling report - TradingView
Investor Short Report Flags Steep Downside Risk For iRhythm Technologies - Benzinga
Spruce Point issues strong sell report on iRhythm Technologies - MarketScreener
Spruce Point says it’s short iRhythm, sees 40%-70% potential LT downside - TipRanks
Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on iRhythm Technologies (NASDAQ: IRTC) - Business Wire
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority - The Manila Times
428,707-Patient Study: iRhythm's Heart Monitor Doubles Diagnosis Rate, Cuts Healthcare Costs by $816/Patient - Stock Titan
iRhythm Technologies Inc. Crosses 200 Day MA — Signal or Noise2025 Technical Patterns & Fast Entry and Exit Trade Plans - sundaytimes.kr
Introducing the CSO finalists in our C-Suite Leaders Awards - The Business Journals
Published on: 2025-08-14 23:53:49 - classian.co.kr
ECG Patch and Holter Monitor Market Set to Witness Significant - openPR.com
Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know - Yahoo Finance
Local health-tech startup secures $2.3M to accelerate AI tools, double workforce - The Business Journals
IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook - Yahoo Finance
Morgan Stanley Raises iRhythm (IRTC) Price Target, Maintains Overweight Rating - MSN
Artificial Intelligence in Remote Patient Monitoring Market - openPR.com
Artificial Intelligence in Remote Patient Monitoring Market Poised to Grow at 27.13% CAGR Through 2032, Reports DelveInsight | Medtronic, iRhythm, Philips, Siemens Healthineers, GE HealthCare, etc - Barchart.com
Morgan Stanley Maintains Buy Rating for Irhythm Technologies with $195 Price Target - AInvest
Chad Patterson Sells 2,555 Shares of iRhythm Technologies Inc, Modestly Overvalued According to GF Value - AInvest
Don't Ignore The Insider Selling In iRhythm Technologies - simplywall.st
iRhythm Technologies' Chief Commercial Officer Sells 2,555 Shares - AInvest
iRhythm Fails to Halt Information Exchange in Investor Lawsuit - Bloomberg Law News
Top Executives Cash Out Big on Irhythm Technologies Stock! - TipRanks
Top Executives Cash Out on Irhythm Technologies Stock Amid Strong Earnings and Raised Price Targets. - AInvest
Stewart Won't Reconsider Her 1st Settled Expectations Denial - Law360
Stewart Denies iRhythm’s Bid to Review Decision Scrapping IPRs Based on ‘Settled Expectations’ - IPWatchdog.com
Insider Selling at iRhythm Technologies: Signal or Noise in a High-Flying Stock? - AInvest
Truist Financial Reiterates Buy Rating for Irhythm Technologies with $175 Price Target - AInvest
iRhythm Technologies Sees Boosted Price Target Following Strong Earnings - AInvest
Why Are iRhythm Technologies Shares Dropping? - TipRanks
Is It Too Late To Consider Buying IRhythm Technologies, Inc. (NASDAQ:IRTC)? - 富途牛牛
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
What is the risk reward ratio of investing in iRhythm Technologies Inc. stockMaximize portfolio growth with strategic plans - Jammu Links News
What analysts say about iRhythm Technologies Inc. stockRapidly growing investment returns - Jammu Links News
How strong is iRhythm Technologies Inc. company’s balance sheetCapitalize on momentum-driven stocks - Jammu Links News
iRhythm’s Strategic Moves and Strong Q2 Performance Boost Stock - StocksToTrade
When is iRhythm Technologies Inc. stock expected to show significant growthUnlock superior stock analysis tools - Jammu Links News
How volatile is iRhythm Technologies Inc. stock compared to the marketTap into rapid wealth building techniques - Jammu Links News
Is iRhythm Technologies Inc. a growth stock or a value stockExponential return rates - Jammu Links News
What catalysts could drive iRhythm Technologies Inc. stock higher in 2025Achieve consistent profits with proven strategies - Jammu Links News
Is it the right time to buy iRhythm Technologies Inc. stockMaximize portfolio value with smart investment plans - Jammu Links News
How many analysts rate iRhythm Technologies Inc. as a “Buy”Identify breakout stocks before they peak - Jammu Links News
How does iRhythm Technologies Inc. compare to its industry peersBuild a diversified portfolio for risk management - Jammu Links News
What are the latest earnings results for iRhythm Technologies Inc.Tremendous return rates - Jammu Links News
Does iRhythm Technologies Inc. stock perform well during market downturnsBuild wealth steadily with smart stock selection - Jammu Links News
What institutional investors are buying iRhythm Technologies Inc. stockGame-changing capital returns - Jammu Links News
What are iRhythm Technologies Inc. company’s key revenue driversRapid profit acceleration - Jammu Links News
iRhythm Technologies Reports Strong Q2 2025 Earnings - The Globe and Mail
iRhythm Technologies (IRTC): Is This MedTech Innovator Poised for Sustained Growth Amid Strategic AI Collaborations and Strong Q2 Performance? - AInvest
Irhythm Technologies Inc Azioni (IRTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Irhythm Technologies Inc Azioni (IRTC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| TALWALKAR ABHIJIT Y | Director |
Aug 11 '25 |
Option Exercise |
10.71 |
5,312 |
56,892 |
25,611 |
| TALWALKAR ABHIJIT Y | Director |
Aug 11 '25 |
Sale |
158.02 |
5,312 |
839,381 |
20,299 |
1.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):